In vitro and in vivo antibacterial activities of CS-940, a new 6-fluoro-8-difluoromethoxy quinolone

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 5, 1996, Pages 1201-1207

  Masuda, Nobuhisa ^a,b   Takahashi, Yoshie ^a   Otsuki, Masako ^a   Ibuki, Etsuyo ^a   Miyoshi, Hidenobu ^a   Nishino, Takeshi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 CYCLOPROPYL 8 DIFLUOROMETHOXY 6 FLUORO 1,4 DIHYDRO 7 (3 METHYL 1 PIPERAZINYL) 4 OXO 3 QUINOLINECARBOXYLIC ACID; CIPROFLOXACIN; LEVOFLOXACIN; QUINOLONE; SPARFLOXACIN; TOSUFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; DRUG ACTIVITY; GRAM NEGATIVE AEROBIC RODS AND COCCI; GRAM POSITIVE BACTERIUM; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CIPROFLOXACIN; DRUG EVALUATION, PRECLINICAL; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MALE; MICE; NAPHTHYRIDINES; PIPERAZINES; PNEUMONIA, BACTERIAL; QUINOLONES;

EID: 0029940588     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.5.1201     Document Type: Article

References (19)

1. Bliss, C. I. 1934 The method of probits Science 79:38-39.
2. Committee for Revision of MIC Determination Method, 1981. Revision of minimal inhibitory concentration (MIC) determination method. Chemotherapy (Tokyo) 29:76-79.
3. Fujimaki, K., T. Noumi, I. Saikawa, M. Inoue, and S. Mitsuhashi. 1988. In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone. Antimicrob. Agents Chemother. 32:827-833.
4. Fujimoto, T., and S. Mitsuhashi. 1990. In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin. Chemotherapy (Basel) 36:268-276.
5. Hisaoka, M., A. Kurihara, Y. Yamashita, H. Tsubaki, M. Kazui, K. Nakamura, and S. Kuwahara. 1993. Pharmacokinetics and metabolism of CS-940 in animals, abstr. 1508 In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
6. Hosaka, M., T. Yasue, H. Fukuda, H. Tomizawa, H. Aoyama, and K. Hirai. 1992. In vitro and in vivo antibacterial activity of AM-1155, a new 6-fluoro-8-methoxy qumolone. Antimicrob. Agents Chemother 36:2108-2117.
7. Imada, T., S. Miyazaki, M. Nishida, K. Yamaguchi, and S. Goto. 1992. In vitro and in vivo antibacterial activities of a new qumolone. OPC-17116. Antimicrob. Agents Chemother. 36:573-579.
8. Ito, A., K. Hirai, M. Inoue, H. Koga, S. Suzue, T. Irikura, and S. Mitsuhashi. 1980. In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrob. Agents Chemother. 17:103-108.
9. Kojima, T., M. Inoue, and S. Mitsuhashi. 1989. In vitro activity of AT-4140 against clinical bacterial isolates. Antimicrob. Agents Chemother. 33:1980-1988.
10. Litchfield, J. T., Jr., and F. Wilcoxon. 1949 A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:99-113.
11. Obana, Y., T. Nishino, and T. Tanino. 1985. Therapeutic efficacy of β-lactam and ammoglycoside antibiotics on experimental pneumonia caused by K. pneumoniae B-54 in diabetic mice. J. Antibiot. 37:941-947.
12. Ozaki, M., M. Matsuda, Y. Tomii, K. Kimura, J. Segawa, M. Kitano, M. Kise, K. Shibata. M. Otsuki, and T. Nishino. 1991 In vivo evaluation of NM441, a new thiazeto-quinoline derivative. Antimicrob. Agents Chemother 35:2496-2499.
13. Sato, K., Y. Matsuura, M. Inoue, T. Une, Y. Osada, H. Ogawa, and S. Mitsuhashi. 1982. In vitro and in vivo activity of DL-8280, a new oxazine derivative. Antimicrob. Agents Chemother. 22:559-564.
14. Takahata, M., M. Otsuki, and T. Nishino. 1988. In-vitro and in-vivo activities of T-3262, a new pyridone carboxylic acid. J. Antimicrob. Chemother. 22: 143-154.
15. Tanaka, M., M. Otsuki, T. Une, and T. Nishino. 1990. In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin. J. Antimicrob. Chemother. 26:659-666.
16. Utsui, Y., M. Takashita, N. Masuda, H. Domon, C. Ishii, S. Ohya, H. Yasuda, M. Iwata, T. Kimura, T. Inoue, Y. Fujiwara, T. Katsube, and S. Kuwahara. 1993. In vitro evaluation of CS-940. abstr 1506. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Washington, D.C.
17. Wise, R., J. M. Andrews, and L. J. Edwards. 1983. In vitro activity of Bay 09867, a new quinolone derivative, compared with those of other antimicrobial agents. Antimicrob. Agents Chemother. 23:559-564.
18. Wolfson, J. S., and D. C. Hooper. 1989. Bacterial resistance to quinolones: mechanisms and clinical importance. Rev. Infect. Dis. 11:S960-S968.
19. Yoshida, H., M. Bogaki, S. Nakamura, K. Ubukata, and M. Konno. 1990. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J. Bacteriol. 172:6942-6949.